WEREWOLF THERAPEUTICS, INC. Shares Outstanding (Cover Page)
WEREWOLF THERAPEUTICS, INC. (HOWL) had Shares Outstanding (Cover Page) of 48.60 million shares as of 2026-07-27, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-31
- 2026-07-27: Entity Common Stock, Shares Outstanding 48.60M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 48.60M shares.
- 2026-03-20: Entity Common Stock, Shares Outstanding 48.60M shares.
- 2025-10-29: Entity Common Stock, Shares Outstanding 48.54M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-27 | 48.60M shares 10-Q · filed 2026-07-31 |
| 2026-05-01 | 48.60M shares 10-Q · filed 2026-05-07 |
| 2026-03-20 | 48.60M shares 10-K · filed 2026-03-27 |
| 2025-10-29 | 48.54M shares 10-Q · filed 2025-11-04 |
| 2025-08-08 | 45.73M shares 10-Q · filed 2025-08-14 |
| 2025-05-02 | 44.87M shares 10-Q · filed 2025-05-08 |
| 2025-03-05 | 44.83M shares 10-K · filed 2025-03-11 |
| 2024-11-01 | 44.56M shares 10-Q · filed 2024-11-07 |
| 2024-08-02 | 43.70M shares 10-Q · filed 2024-08-08 |
| 2024-04-29 | 43.46M shares 10-Q · filed 2024-05-03 |
| 2024-03-01 | 42.74M shares 10-K · filed 2024-03-07 |
| 2023-11-10 | 36.19M shares 10-Q · filed 2023-11-14 |
| 2023-08-04 | 35.66M shares 10-Q · filed 2023-08-10 |
| 2023-05-05 | 35.61M shares 10-Q · filed 2023-05-11 |
| 2023-03-17 | 35.28M shares 10-K · filed 2023-03-23 |
| 2022-11-04 | 30.74M shares 10-Q · filed 2022-11-10 |
| 2022-08-05 | 29.53M shares 10-Q · filed 2022-08-11 |
| 2022-05-06 | 27.65M shares 10-Q · filed 2022-05-10 |
| 2022-03-18 | 27.65M shares 10-K · filed 2022-03-24 |
| 2021-11-05 | 27.58M shares 10-Q · filed 2021-11-10 |
| 2021-08-06 | 27.57M shares 10-Q · filed 2021-08-12 |
| 2021-06-04 | 27.57M shares 10-Q · filed 2021-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |